Stay Granted in Muscular Dystrophy Clinical Trial Case

Friday, September 19, 2008

The U.S. Court of Appeals for the Third Circuit has granted PTC Therapeutics’ request for a stay of the Federal District Court’s decision on August 20 that would have forced the biotech company to provide its experimental drug PTC124 to 16-year-old Duchenne muscular dystrophy patient Jacob Gunvalson outside its clinical trial process.

[Read More]

MMG Partners With Exco InTouch

Thursday, September 18, 2008

Global patient recruitment and retention firm MMG has partnered with Exco InTouch to provide mobile messaging services to its sponsor clients. According to the Rockville, Md.-based company, Exco’s mobile technology will enable sponsors to quickly identify and pre-screen potential subjects for clinical studies, as well as provide ongoing contact with patients via mobile messages, reducing the amount of input required from study organizers.

[Read More]

eTrials Names Permanent CFO

Wednesday, September 17, 2008

etrials, a Morrisville, NC-based eClinical company, named Joseph (Jay) Trepanier II permanent secretary and CFO, replacing James Clark, who resigned in May. Trepanier had been serving as interim secretary and CFO since May and had previously been etrials’ corporate controller and vice president of finance. etrials is currently in the midst of a CEO search, following the sudden resignation of Eugene Chip” Jennings in July. Vice president of technology Chuck Piccirillo serves as interim CEO.

[Read More]

PharmaNet Stock Plunges 60% After Cancellations

Friday, September 12, 2008

PharmaNet Development Group’s shares plunged more than 60% to less than $10 a share in early morning trading after the contract research organization (CRO) cut its financial guidance for the year. The company expects a loss—instead of the previously predicted profit—following cancellations and postponements of projects by biotech and pharmaceutical companies.

[Read More]

Eurofins AvTech Names New President

Thursday, September 11, 2008

Eurofins AvTech Laboratories, a Portage, MI-based contract research organization (CRO), has appointed three senior-level executives to its management team. Dr. Raymond Farmen was named president. Farmen is responsible for general management, technical and profit/loss decisions for the company. He also will provide technical and scientific direction for method development, bioanalytical, product testing and animal health areas. In addition to Farmen, Dr. Steven Weber has joined AvTech’s senior management team as director, Bioanalytical, and Leon Clark, Jr. is director, Animal Health.

[Read More]

Acurian Offers Performance-based Advertising Contracts

Wednesday, September 10, 2008

Horsham, Pa.-based Acurian has expanded its patient recruitment services to include advertising-based strategies that reduce risks for their clients. Typically, according to Acurian, pharmaceutical, biotech and medical device companies that rely on patient recruitment companies to create centralized advertising campaigns to enroll patients into research studies have little or no recourse if the advertising campaign fails. Acurian’s advertising services offer sponsors performance-based contracts, with payment based on campaign success. Acurian is currently running two large centralized advertising campaigns under performance-based contracts.

[Read More]